Skip to content

GRAIL Inc Sustainability Reports

GRAIL, Inc. is a healthcare company focused on the early detection of cancer through next-generation sequencing and data science. The company develops and commercializes pioneering multi-cancer early detection blood screening tests, such as its flagship Galleri test.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

LEI: 2549009XSNESW3VE8024

FIGI: BBG01N6CGX05

1 reports from 2024 to 2024